Matches in Wikidata for { <http://www.wikidata.org/entity/Q51350528> ?p ?o ?g. }
- Q51350528 description "2016 nî lūn-bûn" @default.
- Q51350528 description "2016 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q51350528 description "2016年の論文" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年学术文章" @default.
- Q51350528 description "2016年學術文章" @default.
- Q51350528 description "2016年學術文章" @default.
- Q51350528 description "2016年學術文章" @default.
- Q51350528 description "2016年學術文章" @default.
- Q51350528 description "2016年學術文章" @default.
- Q51350528 description "2016년 논문" @default.
- Q51350528 description "article científic" @default.
- Q51350528 description "article scientific" @default.
- Q51350528 description "article scientifique" @default.
- Q51350528 description "articol științific" @default.
- Q51350528 description "articolo scientifico" @default.
- Q51350528 description "artigo científico" @default.
- Q51350528 description "artigo científico" @default.
- Q51350528 description "artigo científico" @default.
- Q51350528 description "artikel ilmiah" @default.
- Q51350528 description "artikull shkencor" @default.
- Q51350528 description "artikulong pang-agham" @default.
- Q51350528 description "artykuł naukowy" @default.
- Q51350528 description "artículo científico publicado en 2016" @default.
- Q51350528 description "artículu científicu" @default.
- Q51350528 description "bilimsel makale" @default.
- Q51350528 description "bài báo khoa học" @default.
- Q51350528 description "naučni članak" @default.
- Q51350528 description "scienca artikolo" @default.
- Q51350528 description "scientific article published on 10 October 2016" @default.
- Q51350528 description "scientific article published on 10 October 2016" @default.
- Q51350528 description "scientific article published on 10 October 2016" @default.
- Q51350528 description "teaduslik artikkel" @default.
- Q51350528 description "tieteellinen artikkeli" @default.
- Q51350528 description "tudományos cikk" @default.
- Q51350528 description "vedecký článok" @default.
- Q51350528 description "vetenskaplig artikel" @default.
- Q51350528 description "videnskabelig artikel" @default.
- Q51350528 description "vitenskapelig artikkel" @default.
- Q51350528 description "vitskapeleg artikkel" @default.
- Q51350528 description "vědecký článek" @default.
- Q51350528 description "wetenschappelijk artikel" @default.
- Q51350528 description "wissenschaftlicher Artikel" @default.
- Q51350528 description "επιστημονικό άρθρο" @default.
- Q51350528 description "мақолаи илмӣ" @default.
- Q51350528 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q51350528 description "научна статия" @default.
- Q51350528 description "научная статья" @default.
- Q51350528 description "научни чланак" @default.
- Q51350528 description "научни чланак" @default.
- Q51350528 description "מאמר מדעי" @default.
- Q51350528 description "مقالة علمية نشرت في 10 أكتوبر 2016" @default.
- Q51350528 description "১০ অক্টোবর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q51350528 description "บทความทางวิทยาศาสตร์" @default.
- Q51350528 description "სამეცნიერო სტატია" @default.
- Q51350528 name "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 name "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 type Item @default.
- Q51350528 label "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 label "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 prefLabel "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 prefLabel "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 P1433 Q51350528-0955AE55-8A2F-4112-BA14-28A344344596 @default.
- Q51350528 P1476 Q51350528-96A129DE-2E15-42CB-A7A9-B983C5F6C27C @default.
- Q51350528 P2093 Q51350528-1EBF52A4-D6F5-4B4F-A7B4-F0BCCFBC79E3 @default.
- Q51350528 P2093 Q51350528-3C1CF0F9-6EF0-4999-A8E5-A067F3247718 @default.
- Q51350528 P2093 Q51350528-3E58E899-A7F1-494C-A724-BA1882A99555 @default.
- Q51350528 P2093 Q51350528-5D7E737C-FD75-45A3-A159-C0DF2123A07C @default.
- Q51350528 P2093 Q51350528-65686CAC-D016-45DF-8265-C36B47B65F9E @default.
- Q51350528 P2093 Q51350528-6AEE7628-B85B-474F-8EB3-4DA0C57BF266 @default.
- Q51350528 P2093 Q51350528-7D865EC5-91B3-45B4-B1E8-CAC2843EBE87 @default.
- Q51350528 P2093 Q51350528-8B0F5F87-828B-4DFE-BCB6-D39C7A040A05 @default.
- Q51350528 P2093 Q51350528-B63544E4-9674-4586-9060-E23284B64A81 @default.
- Q51350528 P2093 Q51350528-CDFB5811-4696-4939-AA30-EC9BABF06C9F @default.
- Q51350528 P2093 Q51350528-F2FB6E6F-BBFA-4215-A01D-4A771AE9E7AD @default.
- Q51350528 P2860 Q51350528-47E644AF-566B-479D-9B78-6D4A30FD5EF7 @default.
- Q51350528 P304 Q51350528-5DB2705E-DD1B-457E-A6A1-4EC3AAF7CA47 @default.
- Q51350528 P31 Q51350528-055D95D2-D378-4DC9-9251-A0B9814FCF83 @default.
- Q51350528 P356 Q51350528-DCDD53BE-85BF-45A3-BEDE-F66187C08546 @default.
- Q51350528 P407 Q51350528-CD5AE281-76E6-40D2-8BED-C7C19E826729 @default.
- Q51350528 P433 Q51350528-EE3FB16F-9F14-44AC-987A-F7A685E531B4 @default.
- Q51350528 P478 Q51350528-F3BF52FD-4F28-4FD1-9300-E491BA8AD90A @default.
- Q51350528 P577 Q51350528-8268985C-CE15-45B9-B5E4-DB0CE9A3D439 @default.
- Q51350528 P698 Q51350528-6C4B0356-9BED-4D13-93B3-741F8F082DE4 @default.
- Q51350528 P921 Q51350528-DF47C15E-2F98-4B65-B6A4-60ADA494B587 @default.
- Q51350528 P356 1078-0432.CCR-16-1418 @default.
- Q51350528 P698 27803065 @default.
- Q51350528 P1433 Q332253 @default.
- Q51350528 P1476 "A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer." @default.
- Q51350528 P2093 "Alain P Algazi" @default.
- Q51350528 P2093 "Brian Moser" @default.
- Q51350528 P2093 "James E Wooldridge" @default.
- Q51350528 P2093 "Jay Tuttle" @default.
- Q51350528 P2093 "Jonathan W Goldman" @default.
- Q51350528 P2093 "Lee S Rosen" @default.
- Q51350528 P2093 "Michaela Banck" @default.